Psychotropic medication in chronic spinal disorders

Spine Journal

Volumn 4, Issue 4, 2004, Pages 436-450

  Polatin, Peter B ^a   Dersh, Jeffrey ^b  

^a Dept of Anesthesia/Pain Management   (United States)

^b PRIDE Research Foundation   (United States)

Author keywords

Analgesics; Anxiety disorders; Chronic pain; Depressive disorders; Mental disorders; Musculoskeletal diseases; Psychopharmacology; Psychotropic drugs; Spinal diseases; Spinal disorders

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; CYCLOBENZAPRINE; ESCITALOPRAM; ETIRACETAM; FELBAMATE; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; MIRTAZAPINE; MUSCLE RELAXANT AGENT; NEFAZODONE; NEUROLEPTIC AGENT; OXCARBAZEPINE; PAROXETINE; PHENYTOIN; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SERTRALINE; TIAGABINE; TOPIRAMATE; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ANALGESIA; ANEMIA; ANXIETY DISORDER; ATAXIA; BONE MARROW SUPPRESSION; CHRONIC DISEASE; COMORBIDITY; CONFUSION; CONSTIPATION; CONTINUING EDUCATION; DEPRESSION; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG INDICATION; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; HYPERTENSION; INCREASED APPETITE; INSOMNIA; IRRITABILITY; LOW BACK PAIN; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; MENTAL DISEASE; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NOCICEPTION; NYSTAGMUS; ORTHOSTATIC HYPOTENSION; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; RESTLESSNESS; REVIEW; SEDATION; SLURRED SPEECH; SOMNOLENCE; SPINAL CORD DISEASE; SWEAT GLAND DISEASE; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT OUTCOME; TREMOR; URINE RETENTION; VISUAL IMPAIRMENT; XEROSTOMIA;

CHRONIC DISEASE; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MENTAL DISORDERS; PAIN MEASUREMENT; PSYCHOTROPIC DRUGS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPINAL DISEASES; TREATMENT OUTCOME;

EID: 3342916687     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2004.01.012     Document Type: Review

References (79)

1. Dersh J. Gatchel R.J. Polatin P. Chronic spinal disorders and psychopathology: research findings and theoretical considerations Spine J 1 2 2001 88-94
2. Schofferman J. Long term opioid analgesic therapy for severe refractory lumbar spine pain Clin J Pain 15 1999 136-140
3. Portnoy R.K. Current pharmacotherapy of chronic pain J Pain Symptom Manage 19 1 2000 S16-S20
4. Gatchel R.J. Early development of physical and mental deconditioning in painful spinal disorders in: Mayer T.G. Mooney V. Gatchel R.J. eds. Contemporary conservative care for painful spinal disorders 1991 278-289 Lea and Feibiger Philadelphia, PA
5. Gatchel R.J. Psychological disorders and chronic pain: cause and effect relationships in: Gatchel R.J. Turk D.C. eds. Psychological approaches to pain management: a practitioner's handbook 1996 33-52 Guilford Publications New York
6. Polatin P.B. Kinney R.K. Gatchel R.J. Lillo E. Mayer T.G. Psychiatric illness chronic low back pain Spine 18 1993 66-71
7. Dersh J. Gatchel R.J. Polatin P. Mayer T. Prevalence of psychiatric disorders in patients with chronic work-related musculoskeletal pain disability J Occup Environ Med 44 5 2002 459-468
8. Banks S.M. Kerns R.D. Explaining high rates of depression in chronic pain: a diathesis-stress framework Psychol Bull 119 1996 95-110
9. Rockers D.M. Fishman S.M. Pain and affective disorders in: Ballantyne J. Fishman S.M. Abdi S. eds. The Massachussetts General Hospital handbook of pain management 2nd ed 2002 506-512 Lippincott Williams and Wilkins Philadelphia
10. Sullivan M. Katon W. Somatization: the path between distress and somatic symptoms Am Pain Soc J 2 1993 141-149
11. Barsky A.J. Klerman G.L. Overview: hypochondriasis, bodily complaints, and somatic styles Am J Psychiatry 140 1983 273-283
12. Simon G.E. Somatization and psychiatric disorders in: Kirmayer L.J. Robbins J.M. eds. Current concepts of somatization: research and clinical applications 1991 37-62 American Psychiatric Press Washington, DC
13. Polatin P.B. Integration of pharmacotherapy with psychological treatment in: Gatchel R.J. Turk D.C. eds. Psychological approaches to pain management: a practitioner's handbook 1996 305-328 Guilford Publications New York
14. Lynch M.E. Antidepressants as analgesics: a review of randomized controlled studies J Psychiatr Neurosci 26 1 2001 30-36
15. Rockers D.M. Fishman S.M. Psychopharmacology for the pain specialist in: Ballantyne J. Fishman S.M. Abdi S. eds. The Massachussetts General Hospital handbook of pain management 2nd ed 2002 138-152 Lippincott Williams and Wilkins Philadelphia, PA
16. Piccinelli M. Simon G. Gender and cross-cultural differences in somatic symptoms associated with emotional distress: an international study in primary care Psychol Med 27 1997 433-444
17. Fishbain D.A. Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient Med Clin North Am 83 1999 737-763
18. O'Malley P.G. Jackson J.L. Santoro J. Tomkins G. Balden E. Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes J Fam Pract 48 12 1999 980-990
19. Schatzberg A.F. Cole J.O. DeBattista C. Manual of clinical psychopharmacology 4th ed. 2003 American Psychiatric Publishing Washington, DC
20. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Association Washington, DC
21. Slaby A.E. Tancredi L.R. Micropharmacology: treating disturbances of mood, thought, and behavior as specific neurotransmitter dysregulations rather than as clinical syndromes Primary Psychiatry 8 4 2001 28-33
22. Atkinson J. Psychopharmacological agents in the treatment of pain syndromes in: Tollison D. ed. Handbook of chronic pain management 1989 69-102 Williams and Wilkins Baltimore, MD
23. Monks R. Psychotropic drugs in: Wall P. Melzack R. eds. Textbook of pain 3rd ed 1994 963-989 Churchill Livingston New York
24. Onghena P. Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies Pain 40 1992 205-219
25. Sawynok J. Esser M.J. Reid A.R. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action J Psychiatr Neurosci 26 1 2001 21-29
26. Ansari A. The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature Harvard Rev Psychiatry 7 5 2000 257-277
27. Seaman D.R. Cleveland C. Spinal pain syndromes: nociceptive, neuropathic, and psychological mechanisms J Manipulative Physiol Ther 22 7 1999 458-472
28. Moulin D.E. Systemic drug treatment for chronic musculoskeletal pain Clin J Pain 17 2001 S86-S93
29. Salerno S.M. Browning R. Jackson J.L. The effect of antidepressant treatment on chronic back pain: a meta-analysis Arch Intern Med 162 2002 19-24
30. Dickens C. Jayson M. Sutton C. Creed F. The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain Psychosomatics 41 6 2000 490-499
31. Blier P. Abbot F.V. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain J Psychiatr Neurosci 26 1 2001 37-43
32. Sabroe R.A. Kennedy C.T. Archer C.B. The effects of topical doxepin on responses to histamine, substance P, and prostaglandin E2 in human skin Br J Dermatol 137 3 1997 386-390
33. Gilmor M.L. Owens M.J. Nemeroff C.B. Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine Am J Psychiatry 159 10 2002 1702-1710
34. Watson C.P.N. The treatment of neuropathic pain: antidepressants and opioids Clin J Pain 16 2000 S49-S55
35. Fine P.G. Vallerand A.H. Optimizing treatment of chronic pain with opioid therapy [monograph 1] Appropriate opioid pharmacotherapy for chronic pain management [from the National Pain Education Council] 2002 11-43 Discovery International Deerfield, IL
36. Galer B.S. Jensen B.P. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale Neurology 48 2 1997 332-338
37. Jenson M.G. The role of selective serotonin reuptake inhibitors in the management of neuropathic pain Pain Clin 3 2002 18-21
38. Carter G.T. Galer B.S. Advances in the management of neuropathic pain Phys Med Rehab Clin North Am 12 2 2001 447-459
39. Markman J.D. Oaklander A.L. Neuropathic pain syndromes in: Ballantyne J. Fishman S.M. Abdi S. eds. The Massachussetts General Hospital handbook of pain management 2nd ed 2002 339-359 Lippincott Williams and Wilkins Philadelphia
40. Semenchuk M.R. Sherman S. Davis B. Double-blind, randomized trial of buproprion SR for the treatment of neuropathic pain Neurology 57 9 2001 1583-1588
41. France R. Houpt J. Ellinwood E. Therapeutic effects of antidepressants in chronic pain Gen Hosp Psychiatry 6 1984 55-63
42. Urban B. France R. Sternberger E. Long-term use of narcotic/antidepressant medication in the management of phantom limb pain Pain 24 1986 191-196
43. Cluff R.S. Adjuvant treatments in: Ballantyne J. Fishman S.M. Abdi S. eds. The Massachussetts General Hospital handbook of pain management 2nd ed 2002 125-137 Lippincott Williams and Wilkins Philadelphia
44. Attal N. Chronic neuropathic pain: mechanisms and treatment Clin J Pain 16 2000 S118-S130
45. Mao J. Chen L. Gabapentin in pain management Anesth Analg 91 2000 680-687
46. Mellegers M.A. Furlan A.D. Mailis A. Gabapentin for neuropathic pain; systemic review of controlled and uncontrolled literature Clin J Pain 17 2001 284-295
47. Tremont-Lukats I. Megeff C. Backonja M.M. Anticonvulsants for neuropathic pain syndromes: mechanism of action and place in therapy Drugs 60 5 2000 1029-1052
48. Ipponi A. Lamberti C. Medica A. Bartolini A. Malmberg-Aiello P. Tiagabine antinociception in rodents depends on GABAB receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis Euro J Pharm 368 1999 205-211
49. Hering R. Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double blind study versus placebo Cephalalgia 12 1992 81-84
50. Schofferman J. The use of medications for low back pain in: Cole A.J. Herring S.A. eds. The low back pain handbook 2nd ed 2003 133-149 Hanley and Belfus Philadelphia, PA
51. Browning R. Jackson J.L. O'Malley P.G. Cyclobenzaprine and back pain: a meta-analysis Arch Intern Med 161 13 2001 1613-1620
52. Gross L. Metaxalone: a review of clinical experience J Neurol Orthop Med Surg 18 1998 76-79
53. Steardo L. Leo A. Efficacy of baclofen in trigeminal neuralgia and some other painful conditions: a clinical trial Eur Neurol 23 1984 51-55
54. Littrell R. Hayes L. Stillner V. Carisoprodol (Soma): a new cautious perspective on an old agent South Med J 86 7 1987 753-756
55. Bailey D.N. Briggs J.R. Carisoprodol: an unrecognized drug of abuse Am J Clin Pathol 117 3 2002 396-400
56. Logan B.K. Case G.A. Gordon A.M. Carisoprodol, meprobomate, and driving impairment J Forensic Sci 45 3 2000 619-623
57. Berry H. Hutchinson D. Tizanidine and ibuprofen in acute low back pain: results of a double-blind multicentre study in general practice J Int Med Res 16 1988 83-91
58. Semenchuk M. Sherman S. Effectiveness of tizanidine in neuropathic pain: an open-label study J Pain 4 2000 285-292
59. Ballenger J.C. Davidson J.R.T. Lecrubier Y. et al. Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety J Clin Psychiatry 62 suppl 11 2001 53-62
60. Gorman J.M. Treatment of generalized anxiety disorder J Clin Psychiatry 63 suppl 8 2002 17-23
61. France R. Krishnan K. Psychotropic drugs in chronic pain in: France R. Krishnan K. eds. Chronic pain 1988 323-374 American Psychiatric Press Washington, DC
62. Wilsey B.L. Fishman S.M. Chronic opioid therapy, drug abuse, and addiction in: Ballantyne J. Fishman S.M. Abdi S. eds. The Massachussetts General Hospital handbook of pain management 2nd ed 2002 495-505 Lippincott Williams and Wilkins Philadelphia, PA
63. Sussman N. Benzodiazepines: do they still have a clinical role in the treatment of panic disorder Prim Psychiatry 8 2001 35-38
64. Hilty D.M. Hales R.E. Servis M.E. Nuovo J. Algorithms for the diagnosis and treatment of anxiety disorders in the primary care setting Prim Psychiatry 8 2001 58-67
65. Rocca P. Fonzo V. Scotta M. Paroxetine efficacy in the treatment of generalized anxiety disorder Acta Psychiatr Scand 95 1997 444-450
66. Wilson K.G. Eriksson M.Y. D'Eon J.L. Mikail S.F. Emery P.C. Major depression and insomnia in chronic pain Clin J Pain 18 2002 77-83
67. Lim R.F. Hilty D.M. Jerant A.F. An algorithm for treating psychotic disorders in primary care Prim Psychiatry 8 8 2001 68-72
68. Uppington J. Opioids in: Ballantyne J. Fishman S.M. Abdi S. eds. The Massachussetts General Hospital handbook of pain management 2nd ed 2002 103-124 Lippincott Williams and Wilkins Philadelphia, PA
69. Barkin R.L. Barkin D. Pharmacological management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection South Med J 94 8 2001 756-770
70. Lange-Asschenfeldt C. Weighmann H. Hiemke C. Mann K. Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse J Clin Psychopharmacol 22 4 2002 440-441
71. Egberts A.C. ter Borgh J. Brodie-Meijer C.C. Serotonin syndrome attributed to tramadol addition to paroxetine therapy Int Clin Psychopharmacol 12 1997 181-182
72. Ripple M.G. Pestaner J.P. Levine B.S. Smialek J.E. Lethal combination of tramadol and multiple drugs affecting serotonin Am J Forens Med Pathol 21 4 2000 370-374
73. Laska E. Sunshine A. Caffeine as an analgesic adjuvant JAMA 251 1984 1711-1718
74. Schactel B. Fillingim J. Caffeine as an analgesic adjuvant. A double-blind study comparing aspirin with caffeine to aspirin and placebo in patients with sore throat Arch Intern Med 151 1991 733-737
75. Sunshine A. Olson N. Non-narcotic analgesics in: Wall P. Melzack R. eds. Textbook of pain 1994 923-942 Churchill Livingston New York
76. Beck A.T. Beck Depression Inventory 1978 Center for Cognitive Therapy Philadelphia, PA
77. Spitzer R.L. Williams J.B.W. Kroenke K. et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study JAMA 272 1994 1749-1756
78. Spitzer R.L. Kroenke K. Williams J.B.W. Validation and utility of a self-report version of PRIME-MD JAMA 282 18 1999 1737-1744
79. Strain E.C. Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients Clin J Pain 18 2002 S14-S27